AI-assisted, human-published
06/24/2024 /Funding Events
EpilepsyGTx Secures $10M in Seed Funding for Groundbreaking Gene Therapy Program
Biotech company, EpilepsyGTx, raises $10 million in seed funding to advance gene therapy for focal refractory epilepsy, aiming to make patients seizure-free.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com